www.BuyersGuideChem.com - company information on Hubei Zhuxi Humanwell Pharmaceutical Co.Ltd
english deutsch español







Information on
to http://www.zxhumanwell.com

Hubei Zhuxi Humanwell Pharmaceutical Co.Ltd

Company Type: Leading producer
Founded in 2011 and located in the Industrial park of Zhuxi County, Shiyan city, Zhuxi Humanwell Pharmaceutical is a modern high-tech enterprise, specialized in development, production and sales of hormones APIs & intermediates. It covers an area of 133000㎡ with construction area of 24000㎡. Currently there are three workshops for hormones production in the first-stage project. It is mainly engaged in production of progesterone, 16-dehydropregnenolone acetate (16-DPA), pregnenolone, dehydroisoandrosterone (DHEA), dehydroisoandrosterone acetate etc. The total annual production capacity of hormones can reach over 600 tons, including 200 tons/year of 16DPA. In 2015, our company obtained CFDA GMP certificate meanwhile all main products are certified with Written Confirmation for active substance exported to EU.
Products
Hubei Zhuxi Humanwell Pharmaceutical Co.Ltd offers 12 chemical products. You can view the product list

location
Address Hubei Zhuxi Humanwell Pharmaceutical Co.Ltd
APIs overseas sales department
Industrial Park, Zhuxi County
Shiyan City, Hubei Province 442300, P.R.China
Phone +86-18607187965
Fax +86-27-87596835
send an inquiry
Sales contact Childe Tan
Homepage www.zxhumanwell.com

 
Your inquiry to Hubei Zhuxi Humanwell Pharmaceutical Co.Ltd
Your detailed inquiry

Information on your company
 
Your name *
Company name *
Country *  e.g. USA, UK, China, Germany ...
e-Mail *
(one email address only!)

You may insert a short information on your company
The company address, the homepage address and a short company profile.

Information: The mail server will return a copy of this message to you as an acknowledgement. This can take some time. The data of your company will be stored in a cookie on your computer for repeated use - if you allow cookies.

© Copyright 1996 to 2024 by Netvertise GmbH. All rights reserved